{"title":"Traitements médicamenteux préventifs des ostéoporoses","authors":"Clément Nachef , Christian Roux","doi":"10.1016/j.monrhu.2022.07.002","DOIUrl":null,"url":null,"abstract":"<div><p>Osteoporosis and fragility fractures represent a public health issue, responsible for an increased morbidity and mortality. We should consider the prevention of this chronic disease. We can differentiate primary prevention, meaning bone loss prevention in patients with normal bone density, and secondary prevention, meaning fracture prevention in patients with low bone density. We will not discuss about tertiary prevention, which is prevention of fracture recurrence. We will discuss here drug prevention treatment in post-menopausal women, in cancer with hormonotherapy, and in cortico-induced osteoporosis.</p></div>","PeriodicalId":101125,"journal":{"name":"Revue du Rhumatisme Monographies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue du Rhumatisme Monographies","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878622722000728","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Osteoporosis and fragility fractures represent a public health issue, responsible for an increased morbidity and mortality. We should consider the prevention of this chronic disease. We can differentiate primary prevention, meaning bone loss prevention in patients with normal bone density, and secondary prevention, meaning fracture prevention in patients with low bone density. We will not discuss about tertiary prevention, which is prevention of fracture recurrence. We will discuss here drug prevention treatment in post-menopausal women, in cancer with hormonotherapy, and in cortico-induced osteoporosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
